Fraxone 250 mg and 1 g Powder for Injection,
PDF Leaflet Revision Date: 01 October 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of infections caused by susceptible organisms.
Dosage (summary)
Adults: 1-2 g once daily; severe cases: up to 4 g once daily.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established; crosses placenta and excreted in breast milk.
Key Drug Interactions
- Calcium-containing products
- Aminoglycosides
- Vitamin K antagonists
Contraindications
- Hypersensitivity to ceftriaxone
- Premature neonates
- Hyperbilirubinemic newborns
Common side effects
- Diarrhoea
- Rash
- Eosinophilia
- Injection site pain
Counselling Points
- Monitor for allergic reactions
- Avoid calcium-containing solutions
- Report any severe gastrointestinal symptoms
Serious warnings
- Serious hypersensitivity reactions
- Clostridium difficile associated diarrhoea
- Risk of bilirubin encephalopathy in neonates
Important Disclaimer
The Fraxone 250 mg and 1 g Powder for Injection, professional information leaflet below is the property of Innovata Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
